Dr. William Charles Cole Claiborne, MD, MPH

Dr. Claiborne practices at Claiborne & Associates in New Orleans, Louisiana.

Dr. Claiborne's NPI, 1518266402, was assigned on March 18, 2011. Dr. Claiborne graduated from Tulane University School of Medicine in 2011. Dr. Claiborne holds Louisiana license MD.205449.

Dr. Claiborne's primary practice is Claiborne & Associates, at 1477 Louisiana Ave, New Orleans, LA 70115 in Orleans Parish. The practice phone is (504) 895-4339.

Dr. Claiborne's primary practice is Claiborne & Associates in New Orleans, Louisiana. The medical group on file is MD Claiborne & Associates. Dmand AI also links Dr. Claiborne to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Claiborne practices. Vendor and product names are available with a free account.

Dermatology is Dr. Claiborne's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Claiborne is licensed in Louisiana.

CMS data shows 3,747 Medicare services from Dr. Claiborne across 23 procedure codes in 2024, for 357 Medicare patients. Medicare paid $140,791 for them. Every service was in an office.

CMS counts 357 Medicare patients who saw Dr. Claiborne in 2024. The largest group is 65 to 74, with 188 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Claiborne's median patient age at 70, with 45% women.

In 2024, Dr. Claiborne wrote 1,707 Medicare Part D claims for 657 patients. 92% of them were for generic drugs. CMS names the drug for 1,612 of them, across 19 drugs with 11 or more claims each, at $680,308 in total drug cost. In 2023, CMS named 1,306 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Claiborne for performance year 2024, reported as part of a group. Dr. Claiborne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,275 procedures of removal of skin lesions by Dr. Claiborne, more than 95% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Claiborne to 1 clinical trial. Conditions studied include Eczema and Dermatitis, Atopic. Open Payments lists research payments to Dr. Claiborne that name 1 trial.

CMS Open Payments shows 906 general payments to Dr. Claiborne from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. Sanofi and Genzyme US Companies paid the most, $167,360. It also lists 1 research payment totaling $2 in 2023, naming 1 clinical trial.

Dr. Claiborne graduated from Tulane University School of Medicine in 2011.